EXACT SCIENCES CORPEXASEarnings & Financial Report
Nasdaq · health care industry
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 11.90% | 22.0M | — | 2024-10-07 |
| The Vanguard Group | 9.71% | 17.6M | — | 2024-02-13 |
| OF ABOVE PERSONS | 8.60% | 15.8M | — | 2024-11-13 |
| Wellington Management Group LLP | 7.93% | 14.7M | ▲ +2.10pp | 2024-11-08 |
| Genomic Health, Inc. | 7.10% | 3.4M | — | 2024-10-04 |
| BlackRock, Inc. | 6.10% | 11.1M | — | 2024-01-29 |
| NOS. OF ABOVE PERSONS | 4.00% | 7.5M | ▼ -5.50pp | 2024-06-07 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-23 | Conroy Kevin T | President and CEO | Grant | 119.3K | $0.00 | $0 |
| 2026-03-23 | Conroy Kevin T | President and CEO | Disposition | 1.40M | — | — |
| 2026-03-23 | Conroy Kevin T | President and CEO | Disposition | 29.1K | — | — |
| 2026-03-23 | Conroy Kevin T | President and CEO | Disposition | 46.5K | — | — |
| 2026-03-23 | Conroy Kevin T | President and CEO | Disposition | 86.8K | — | — |
| 2026-03-23 | Conroy Kevin T | President and CEO | Disposition | 117.4K | — | — |
| 2026-03-23 | James Herriott | SVP, General Counsel & Sec | Disposition | 68.2K | — | — |
| 2026-03-23 | James Herriott | SVP, General Counsel & Sec | Disposition | 1.8K | — | — |
| 2026-03-23 | Aaron Bloomer | EVP, Chief Financial Officer | Grant | 89.9K | $0.00 | $0 |
| 2026-03-23 | Aaron Bloomer | EVP, Chief Financial Officer | Disposition | 138.7K | — | — |
1–10 of 43
Page 1 / 5